期刊文献+

慢性心力衰竭患者外周血单核细胞TNF-α mRNA转录和蛋白质表达的改变及开博通的干预作用

Expression changes of tumor necrosis factor mRNA and protein in PBMC of patients with chronic heart failure and influence of ACEI on it
下载PDF
导出
摘要 目的 通过测定慢性充血性心力衰竭 (CHF)患者外周血单核细胞肿瘤坏死因子 - α(TNF- α) m RNA转录和蛋白质表达的改变 ,及血管紧张素转换酶抑制剂开博通对其的影响 ,探讨 TNF- α在 CHF发病中的作用、可能来源及与肾素 -血管紧张素系统的关系。方法 收集 2 0例 CHF患者及 10例健康人外周血单核细胞 (PBMC) ,应用 RPMI16 4 0培养基进行培养 ,并加入开博通 ,使开博通终浓度分别为 0 m mol/ L ,10 - 8mmol/ L。 2 4 h后 ,取培养 PBMC,应用 RT- PCR和Western blot技术测定 CHF患者和正常对照组外周血单核细胞 TNF-α m RNA转录和蛋白质表达的变化。结果 与正常对照组相比 ,CHF患者外周血单核细胞 TNF-α m RNA转录水平、TNF-α蛋白的相对含量高于对照组。开博通对CHF组 PBMC TNF- α m RNA转录和蛋白质表达有抑制作用。结论  (1) CHF患者 TNF- α m RNA及蛋白质表达增加 ,提示 TNF- α可能参与了心力衰竭的发生发展过程。 PBMC可能是心力衰竭时 TNF- α表达增加的一个来源。 (2 )TNF- α m RNA及蛋白质表达增加可能与心力衰竭时肾素 Objective To study the expression changes of tumor necrosis factor(TNF-α) mRNA and protein in patients with chronic heart failure and influence of angiotensin converting enzyme inhibitors(ACEI) on it. Methods Peripheral blood mononuclear cells (PBMC) was isolated from plasma, which was cultured with RPMI1640 medium for 24h,the conclusion of ACEI was respectively 0 mmol/L, 10 -8 mmol/L,then levels of TNF-α mRNA and protein of PBMC was determined by RT-PCR and Western blot in 20 patients with CHF and 10 health controls. Results The level of TNF-α mRNA and protein of PBMC of patients were higher than the controls. Capoten can inhibit the expression of TNF-α. Conclusion The expression of tumor necrosis factor in patients with chronic heart failure was up regulated, and ACEI can inhibit the expression of TNF-α,which suggested TNF-α and RAS interacted in the development of CHF and PBMC may be the one of source of TNF-α.
出处 《中国心血管杂志》 2003年第6期408-410,共3页 Chinese Journal of Cardiovascular Medicine
关键词 心力衰竭 肿瘤坏死因子-αmRNA 逆转录-聚合酶链反应 免疫印迹分析 血管紧张素转换酶抑制剂 肾素-血管紧张素系统 Chronic heart failure(CHF) TNF-α mRNA RT-PCR Western blot ACEI Renal-angiotensin system
  • 相关文献

参考文献9

  • 1Torre Amione G, Kapasia S, Lee J, et al. Tumor necrosis Factor-a and tumor necrosis factor receptors in the failing human heart [J]. Circulation, 1996,93:704-711.
  • 2Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardio myopathy[J]. Am J Cardol, 1999,83 : 376-382.
  • 3Mann DL,Young JB. Basic Mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines[J]. Chest, 1994,105:897-904.
  • 4Hatakeyama K, Kagamivyama H, Simmons RL, et al. Tetrahydrobiopeterin synthesis and inducible nitric oxide production in pulmonary artery smooth muscle[J]. Am J Physiol,1994,266:455-460.
  • 5Sasaysma S, Mstsumori A . Role of cytokines in the syndrome of heart failure [J]. Internal Medicine,1996, 35:60-63.
  • 6Herrera Garza EH, Stetson S J, Cubillos garzon A, et al. Tumor necrosis factor-a:a mediator of disease progression in the failing human heart[J]. Chest, 1999,115:1170-1174.
  • 7Overbecke CR, Baan CC, Niesters HGM, et al. The TNF-α system in heart failure and after heart transplantation[J]. Eur Heart J, 1999,20 : 833-840.
  • 8Matsumori A, Shioi T, Yamada T, et al. Vesnarinone, a new inotropic agent ,inhibits cytokine production by stimulated human blood from patients withheart failure[J]. Circulation, 1994,89 : 955-958.
  • 9Kenji Nagata,Toshiyuki Lshibashi. Effects of blockade of the rennin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes[J] . Journal of Hypertension, 2001,19:775-783.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部